Biocryst Pharmaceuticals Inc (BCRX)

Operating Expenses

$115.95M

Quarterly · Period ending: · USD

BCRX logo

BCRX Operating Expenses

Latest reported$115.95M
BCRX Quarterly Operating Expenses ($700.00K → $115.95M)
High-resolution chart · PNG

BCRX operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
3,579,000
3,269,000
3,350,608
2,931,000
3,748,000
3,518,779
2,500,000
2,700,000
2,900,000
3,100,000
2,300,000
3,700,000
3,600,000
3,400,000
3,500,000
3,100,000
3,700,000
3,700,000
-4,900,000
2,800,000
3,200,000
2,100,000
-4,500,000
2,300,000
1,900,000
3,300,000
500,000
600,000
800,000
700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.